Advanced Search

 

Study ID Status Title Patient Level Data
29060/282 Completed A trial to assess the effectiveness and tolerance of paroxetine by double-blind comparison with placebo using a novel “shifted crossover” design Study Listed on ClinicalStudyDataRequest.com
29060/283/014B Completed The Short Term Phase of an Open, Long-Term, Safety and Tolerability Study of Paroxetine in Patients Suffering from Depression
29060/284 Completed A comparison of the effect of paroxetine and amitriptyline in single doses on psychomotor performance
29060/285 Completed To assess the effect of repeated dosing with paroxetine, amitriptyline and placebo on psychomotor skills and cardiac function in volunteers
29060/286 Completed An investigation of the pharmacokinetics, efficacy, and tolerance of paroxetine in geriatric patients with depression
29060/287 Completed A Report on the Short-Term Phase of an Open Long-Term Study to Investigate the Safety of Paroxetine in Geriatric Patients
29060/289 Completed A Study to Assess the Efficacy and Tolerance of Paroxetine in Patients with Depression by Double-Blind Comparison with Clomipramine
29060/290 Completed A prospective, randomized, double-blind, multicentre study of the efficacy and tolerance of paroxetine versus clomipramine in the treatment of endogenous depression in the elderly
29060/291 Completed A Multi-Centre Double-Blind Study to Investigate the Safety and Efficacy of Paroxetine in Comparison with Clomipramine in the Treatment of Reactive Depression in Elderly Patients.
29060/292 Completed A multi-centre study to assess the effectiveness and tolerance of paroxetine by double-blind comparison with amitriptyline
29060/294 Completed A study to investigate the effects of food on the bioavailability of a single 20 mg dose of ‘Paxil’ (paroxetine) in healthy volunteers
29060/298 Completed A double-blind study comparing the efficacy and tolerability of paroxetine and placebo in hospital out-patients with depressive symptoms associated with chronic back pain.
29060/299 Completed A Double-Blind Study Comparing The Efficacy and Tolerability of Paroxetine and Amitriptyline In Patients With Severe Depression.
29060/303 Completed A double blind, placebo controlled study to determine the effects of subchronic paroxetine treatment on nocturnal hormonal secretion and sleep in healthy male volunteers
29060/308 Completed Early clinical evaluation of a new antidepressant: A double-blind parallel study comparing paroxetine 30mg daily with amitriptyline 150mg daily
29060/309 Completed Early Clinical Evaluation of a New Antidepressant: A Double-Blind Parallel Study Comparing Paroxetine 30mg Daily with Amitriptyline 100mg Daily
29060/310 Completed Early Clinical Evaluation of a New Antidepressant: Double-Blind Parallel Study Comparing Paroxetine 30mg Daily with Amitriptyline 150mg Daily
29060/311 Completed Early clinical evaluation of a new antidepressant: An open pilot study of paroxetine 40mg daily
29060/312 Completed A Phase II Pharmacokinetic Double Blind Study Comparing Paroxetine with Amitriptyline in Depressed Patients
29060/313 Completed A study to assess the efficacy and pharmacokinetics of paroxetine in depressed geriatric patients
29060/314 Completed Double Blind Parallel Study Comparing Paroxetine, 30mg Daily, and Amitriptyline, 150mg Daily, in Depressed Patients
29060/315 Completed Early clinical evaluation of a new antidepressant: An open pilot study of paroxetine 40mg daily
29060/316 Completed Early Clinical Evaluation of a New Antidepressant: A Double-Blind Parallel Study Comparing Paroxetine 30mg Daily with Amitriptyline 150mg Daily
29060/317 Completed An early clinical evaluation of a new antidepressant: An open study of paroxetine 40mg o.d.
29060/318 Completed Early Clinical Evaluation of a New Antidepressant: A Double-Blind Parallel Study Comparing Paroxetine 30mg Daily with Amitriptyline 150mg Daily

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.